Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/24/1996WO1996032968A1 Compounds for cancer imaging and therapy
10/24/1996WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032951A1 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/24/1996WO1996032950A1 Complexing urushiols
10/24/1996WO1996032948A1 Method for treating dyskinesias
10/24/1996WO1996032947A1 Method for treating nicotine withdrawal
10/24/1996WO1996032946A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
10/24/1996WO1996032945A1 Neovascularization inhibitor
10/24/1996WO1996032944A1 Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor
10/24/1996WO1996032942A1 Compositions, kits, and methods for administration of antilipemic and anti-platelet aggregation drugs
10/24/1996WO1996032941A1 Pranoprofen eyedrops containing organic amine
10/24/1996WO1996032940A1 New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
10/24/1996WO1996032939A1 USE OF α1L AGONISTS IN THE TREATMENT OF INCONTINENCE
10/24/1996WO1996032938A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
10/24/1996WO1996032937A1 Benzothiophenes with novel basic side chains
10/24/1996WO1996032935A1 Inhibition of apoptosis in cells expressing fas-ligand following activation
10/24/1996WO1996032934A1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection
10/24/1996WO1996032933A1 External preparations for treating dermatoses
10/24/1996WO1996032931A2 Composite with sodium starch glycolate as a support material and products thereof
10/24/1996WO1996032906A1 Magnesium taurate as a therapeutic agent
10/24/1996WO1996032850A1 Stress regulator for animals
10/24/1996WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists
10/24/1996WO1996023769A3 Heterocyclic compounds possessing 5ht2c receptor antagonist activity
10/24/1996DE19514579A1 Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz Using alpha¶1¶¶L¶ agonists for treating urinary incontinence
10/24/1996DE19514274A1 Tablet contg. inulin and salts to cause fizzing
10/24/1996CA2218705A1 Fused imidazo¬1,2-a|pyridines
10/24/1996CA2218696A1 Compositions, kits and methods for administration of antilipemic and an ti-platelet aggregation drugs
10/24/1996CA2218685A1 Inhibition of apoptosis in cells expressing fas-ligand following activation
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218648A1 Preparation of clavulanate salts
10/24/1996CA2218636A1 Fatty acid derivatives
10/24/1996CA2218597A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996CA2218562A1 A process for preparing form 1 ranitidine hydrochloride
10/24/1996CA2218512A1 Stress regulator for animals
10/24/1996CA2218486A1 Composite with sodium starch glycolate as a support material and products thereof
10/24/1996CA2218391A1 Alpha 1a adrenergic receptor antagonists
10/24/1996CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors
10/24/1996CA2218345A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
10/24/1996CA2218330A1 1- .omega.-(3,4-dihydro-2-naphthalenyl)alkyl -cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
10/24/1996CA2218322A1 New form of (e)-3- 6- (2,6-dichlorophenyl)-thio methyl -3-(2-phenylethoxy)-2-pyridinyl -2-propenoic acid
10/24/1996CA2218143A1 Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor
10/24/1996CA2218062A1 Method for treating dyskinesias
10/24/1996CA2218020A1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/24/1996CA2218019A1 Method for treating nicotine withdrawal
10/24/1996CA2217865A1 Efflux pump inhibitors
10/24/1996CA2217632A1 Novel triazolones as apolipoprotein-b synthesis inhibitors
10/24/1996CA2216882A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996CA2215902A1 Benzothiophenes with novel basic side chains
10/24/1996CA2215839A1 Compounds for cancer imaging and therapy
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996CA2215264A1 Tumor protease activated prodrugs of phosphoramide mustard analogs
10/24/1996CA2214083A1 Complexing urushiols
10/24/1996CA2193742A1 External preparations for treating dermatoses
10/23/1996EP0738727A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
10/23/1996EP0738726A1 Heterobenzocyclopentane oxazolidinones having antibacterial activity
10/23/1996EP0738725A2 Benzothiophenes with novel basic side chains
10/23/1996EP0738724A2 Process for the preparation of an N-terbutylamide derivative
10/23/1996EP0738722A1 5-Amino-benzofuran-2-carboxylic acid derivatives
10/23/1996EP0738721A1 Forms a and b of n-[[[2-[[[2-[(diaminomethylen)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylen]-4-bromobenzenosulphonamide
10/23/1996EP0738717A1 Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines
10/23/1996EP0738715A2 Arylalkyl-pyridazinones
10/23/1996EP0738714A2 Process for preparing new fibrinogen receptor antagonists
10/23/1996EP0738712A1 Anti-arrhythmic and cardioprotective substituted indenoylguanidines
10/23/1996EP0738515A1 Treatment of nicotine withdrawal
10/23/1996EP0738514A1 Treatment of dyskinesias
10/23/1996EP0738513A1 Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
10/23/1996EP0738512A1 Use of a HMG CoA reductase inhibitor to prevent a second heart attack
10/23/1996EP0738510A2 Use of an HMG-CoA reductase as anti-ageing agent
10/23/1996EP0738508A1 Skin whitening and/or anti ageing composition and its uses
10/23/1996EP0738475A1 Alpha-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/23/1996EP0738328A1 Composition containing nucleic acids, preparation and uses
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738281A1 Peptides and methods against psoriasis
10/23/1996EP0738275A1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
10/23/1996EP0738273A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
10/23/1996EP0738270A1 Dihydro pyrazolopyrroles
10/23/1996EP0738269A1 Novel piperidine derivatives with paf antagonist activity
10/23/1996EP0738268A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
10/23/1996EP0738267A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
10/23/1996EP0738266A1 Taxane derivatives
10/23/1996EP0738265A1 Taxane derivatives
10/23/1996EP0738263A1 Novel optionally substituted phenylimidazolidines, intermediates and process for their preparation, their use as drugs and pharmaceutical compositions containing them
10/23/1996EP0738262A1 Novel heterocyclic compounds
10/23/1996EP0738261A1 Pharmaceutical formulations comprising polythiourea and method of use thereof
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996EP0738153A1 Synthetic insulin mimetic substances
10/23/1996EP0738151A1 Treatment using arachidonic acid metabolite and particulate formulations
10/23/1996EP0738150A1 Bicyclic fibrinogen antagonists
10/23/1996EP0738149A1 1-aminoindan derivatives and compositions thereof
10/23/1996EP0738148A1 Self-assembled taxo-diperpenoid nanostructures
10/23/1996EP0738147A1 Application of riluzole in the treatment of mitochondrial diseases
10/23/1996EP0738145A1 Pharmaceutical compositions
10/23/1996EP0738144A1 Phenylmethyl hexanamides, and the use thereof
10/23/1996EP0738143A1 Curcumin, analogues of curcumin and novel uses thereof
10/23/1996EP0738142A1 Perfluorocarbons as anti-inflammatory agents
10/23/1996EP0738141A1 Sucrose ester c-20 to c-28 alcohol formulations
10/23/1996EP0738107A1 Inhibitors of fatty acid synthesis as antimicrobial agents
10/23/1996EP0678023B1 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes
1 ... 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 ... 7860